Improved Outcomes of All-Trans-Retinoic Acid and Arsenic Trioxide Plus Idarubicin As a Frontline Treatment in Adult Patients with Acute Promyelocytic Leukemia
第一作者单位:[1]Henan Prov Peoples Hosp, Inst Hematol, Zhengzhou, Peoples R China
推荐引用方式(GB/T 7714):
Yang Shiwei,Zhu Zunmin,Zhu Xiaojian,et al.Improved Outcomes of All-Trans-Retinoic Acid and Arsenic Trioxide Plus Idarubicin As a Frontline Treatment in Adult Patients with Acute Promyelocytic Leukemia[J].BLOOD.2019,134:doi:10.1182/blood-2019-128602.
APA:
Yang, Shiwei,Zhu, Zunmin,Zhu, Xiaojian&Zhang, Yicheng.(2019).Improved Outcomes of All-Trans-Retinoic Acid and Arsenic Trioxide Plus Idarubicin As a Frontline Treatment in Adult Patients with Acute Promyelocytic Leukemia.BLOOD,134,
MLA:
Yang, Shiwei,et al."Improved Outcomes of All-Trans-Retinoic Acid and Arsenic Trioxide Plus Idarubicin As a Frontline Treatment in Adult Patients with Acute Promyelocytic Leukemia".BLOOD 134.(2019)